Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.
Cantilena S, Gasparoli L, Pal D, Heidenreich O, Klusmann JH, Martens JHA, Faille A, Warren AJ, Karsa M, Pandher R, Somers K, Williams O, de Boer J.
Cantilena S, et al. Among authors: martens jha.
Clin Transl Med. 2022 Jun;12(6):e933. doi: 10.1002/ctm2.933.
Clin Transl Med. 2022.
PMID: 35730653
Free PMC article.